Surgical Ablation of Atrial Fibrillation will Drive Growth in the European Electrophysiology Mapping and Ablation Market over Coming Years
According to a new report by Millennium Research Group (MRG), the European market (comprised of France, Germany, Italy, and the UK) for EP mapping and ablation will grow by almost $100 million throughout the next 5 years, reaching annual sales of $220 million in 2009.
(PRWEB) May 11, 2005
The use of probes in recreating the Cox-Maze procedure in the treatment of atrial fibrillation (AF) has garnered interest and will significantly drive electrophysiology (EP) device revenue growth in Europe. According to a new report by Millennium Research Group (MRG), the European market (comprised of France, Germany, Italy, and the UK) for EP mapping and ablation will grow by almost $100 million throughout the next 5 years, reaching annual sales of $220 million in 2009.
Nearly 100,000 electrophysiology studie(s) (EPS) and 60,000 catheter ablations procedures were performed in Europe in 2004. This number is expected to increase to 118,000 EPS and 99,000 catheter ablations by 2009. Although EP catheter-based procedure growth is large, 4.1% for EPS and 11.5% for catheter ablations, it pales in comparison to the rapid growth expected to occur in surgical ablation procedure volumes over the next 5 years. The number of surgical ablation procedures in Europe will increase from 6,600 in 2004 to 12,900 by 2009. This growth is largely driven by the aging European population and new device availability.
In 2004, the European surgical ablation market was valued at about $11 million. Less invasive surgical ablation devices, using energy sources such as microwave and laser, will enable the surgical ablation market to experience substantial growth by treating patients suffering from AF—the most common arrhythmia in Europe with a prevalence of over 1.1 million. Procedure growth will increase as physicians begin to recognize the benefits of surgical ablation and its ability to cure AF, and as hospitals increase their funding of the procedure. This will drive the revenues for surgical ablation in Europe to over $24 million by 2009.
MRG's European report is part of its Global Markets for the Electrophysiology Mapping and Ablation Market series, which includes analysis on the United States, Japan, and key industry competitors. The global report series covers over 20 competitors including St. Jude Medical (STJ), Biosense Webster (JNJ), Boston Scientific (BSX), Medtronic (MDT), C. R. Bard (BCR), GE Healthcare (GE), EP Medsystems (EPMD), Cardima (CRDM), and CryoCath Technologies (CYT–TSX).
A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.
Contact Information:
Derrick Navarro
Millennium Research Group Inc.
(416) 364-7776 ext.133
Www. mrg. net
# # #
